16 July 2021GlaxoSmithKline (GSK.NYSE) Announces Positive Headline Results from Five Phase 3…Kieran Robertson GSK.NYSE GlaxoSmithKline (GSK.NYSE) today announced positive headline results from five studies of the Phase 3 ASCEND program, evaluating the efficacy and safety profile of daprodustat, an investigational oral hypoxia-inducible factor…